Distinctive cellular roles for novel protein kinase C isoenzymes

Current Pharmaceutical Design

Volumn 12, Issue 24, 2006, Pages 3117-3133

  Perletti, Gianpaolo ^a   Terrian, D M ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

PKC delta; PKC epsilon; PKC isoenzymes; Protein kinase C

Indexed keywords

CYTOKINE; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C THETA;

APOPTOSIS; B LYMPHOCYTE; BACTERIAL IMMUNITY; BASAL CELL CARCINOMA; CANCER INHIBITION; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME DEFICIENCY; ENZYME STRUCTURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC TRANSCRIPTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART PROTECTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; INHIBITION KINETICS; ISCHEMIC PRECONDITIONING; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RAT; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

ANIMALS; CELL DIVISION; CYTOKINES; HUMANS; IMMUNE SYSTEM; ISOENZYMES; MODELS, BIOLOGICAL; PROTEIN KINASE C-DELTA;

EID: 33747176561     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206777947498     Document Type: Review

References (208)

1. Kofler K, Erdel M, Utermann G, Baier G. Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biol 2002; 3: genomebiology.com/2002/3/3/research/0014.1-0014.10. Epub 2002 Feb 27.
2. Morrish BC, Rumsby MG. The 5′ UTR of protein kinase C epsilon confers translational regulation in vitro and in vivo. Biochem Biophys Res Commun 2001; 283: 1091-8.
3. Suh KS, Tatunchak TT, Crutchley JM, Edwards LE, Marin KG, Yuspa SH. Genomic structure and promoter analysis of PKCδ. Genomics 2003; 82: 57-67.
4. Kurkinen KM, Keinanen RA, Karhu R, Koistinaho J. Genomic structure and chromosomal localization of the rat protein kinase C delta-gene. Gene 2000; 242: 115-23.
5. Romanova LY, Alexandrov IA, Nordan RP, Blagosklonny MV, Mushinski JF. Cross-Talk between Protein Kinase C-α (PKC-α) and -δ (PKC-δ): PKC-δ elevates the PKC-δ protein level, altering its mRNA transcription and degradation. Biochemistry 1998; 37: 5558-65.
6. Pappa H, Murray-Rust J, Dekker LV, Parker PJ, McDonald NQ. Crystal structure of the C2 domain from protein kinase C-delta. Structure 1998; 6: 885-94.
7. Ochoa WF, Garcia-Garcia J, Fita I, Corbalan-Garcia S, Verdaguer N, Gomez-Fernandez JC. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains. J Mol Biol 2001; 311: 837-49.
8. Stahelin RV, Digman MA, Medkova M, Ananthanarayanan B, Melowic HR, Rafter JD, et al. Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: Mechanistic differences between PKCdelta and epsilon. J Biol Chem 2005; 280: 19784-93.
9. Dorn GW 2nd, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci USA 1999; 96: 12798-803.
10. Schechtman D, Craske ML, Kheifets V, Meyer T, Schechtman J, Mochly-Rosen D. A critical intramolecular interaction for protein kinase Cepsilon translocation. J Biol Chem 2004; 279: 15831-40.
11. Garcia-Paramio P, Cabrerizo Y, Bornancin F, Parker PJ. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation. Biochem 11998; 333: 631-6.
12. Stahelin RV, Digman MA, Medkova M, Ananthanarayanan B, Rafter JD, Melowic HR, et al. Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase Cdelta. J Biol Chem 2004; 279: 29501-12.
13. Kashiwagi K, Shirai Y, Kuriyama M, Sakai N, Saito N. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem 2002; 277: 18037-45.
14. Prekeris R, Mayhew MW, Cooper JB, Terrian DM. Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function. J Cell Biol 1996; 132: 77-90.
15. Prekeris R, Hernandez RM, Mayhew MW, White MK, Terrian DM. Molecular analysis of the interactions between protein kinase C-epsilon and filamentous actin. J Biol Chem 1998; 273: 26790-8.
16. Smallwood ND, Hausman BS, Wang X, Liedtke CM. Involvement of NH2 terminus of PKC-delta in binding to F-actin during activation of Calu-3 airway epithelial NKCC1. Am J Physiol Cell Physiol 2005; 288: C906-12.
17. Hernandez RM, Wescott GG, Mayhew MW, McJilton MA, Terrian DM. Biochemical and morphogenic effects of the interaction between protein kinase C-epsilon and actin in vitro and in cultured NIH3T3 cells. J Cell Biochem 2001; 83: 532-46.
18. Tachado SD, Mayhew MW, Wescott GG, Foreman TL, Goodwin CD, McJilton MA, et al. Regulation of tumor invasion and metastasis in protein kinase C epsilon-transformed NIH3T3 fibroblasts. J Cell Biochem 2002; 85: 785-97.
19. Zeidman R, Troller U, Raghunath A, Pahlman S, Larsson C. Protein kinase Cepsilon actin-binding site is important for neurite outgrowth during neuronal differentiation. Mol Biol Cell 2002; 13: 12-24.
20. Leverrier S, Vallentin A, Joubert D. Positive feedback of protein kinase C proteolytic activation during apoptosis. Biochem J 2002; 368: 905-13.
21. Koriyama H, Kouchi Z, Umeda T, Saido TC, Momoi T, Ishiura S, et al. Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cell Signal 1999; 11: 831-8.
22. Lee HW, Smith L, Pettit GR, Smith JB. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/ proteasome pathway in human fibroblasts. Mol Pharmacol 1997; 51: 439-47.
23. Schaap D, Hsuan J, Totty N, Parker PJ. Proteolytic activation of protein kinase C-epsilon. Eur J Biochem 1990; 191: 431-5.
24. Yamano H, Tsurumi C, Gannon J, Hunt T. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor. EMBO J 1998; 17: 5670-8.
25. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A. Regulation of novel protein kinase C epsilon by phosphorylation. Biochem J 2002; 363: 5237-45.
26. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y. Identification of three additional members of rat protein kinase C family: delta-, epsilon- and zeta-subspecies. FEBS Lett 1987; 226: 125-8.
27. Ogita K, Miyamoto S, Yamaguchi K, Koide H, Fujisawa N, Kikkawa U, et al. Isolation and characterization of delta-subspecies of protein kinase C from rat brain. J Biol Chem 1994; 269: 2349-2352.
28. Mizuno K, Kubo K, Saido TC, Akita Y, Osada S, Kuroki T, et al. Structure and properties of a ubiquitously expressed protein kinase C, nPKC delta. Eur J Biochem 1991; 202: 931-40.
29. Huppi K, Siwarski D, Goodnight J, Mischak H. Assignment of the protein kinase C delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. Genomics 1994; 19: 161-2.
30. Kazanietz MG, Wang S, Milne GWA, Lewin NE, Liu HL, Blumberg PM. Residues in the Second Cysteine-rich Region of Protein Kinase C d Relevant to Phorbol Ester Binding as Revealed by Site-directed Mutagenesis. J Biol Chem 1995; 270: 21852-9.
31. Szallasi Z, Bogi K, Gohari S, Biro T, Acs P, Blumberg PM. Non-equivalent roles for the first and second zinc fingers of protein kinase Cdelta. Effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells. J Biol Chem 1996; 271: 18299-301.
32. Hunn M, Quest AF. Cysteine-rich regions of protein kinase Cdelta are functionally non-equivalent. Differences between cysteine-rich regions of non-calcium-dependent protein kinase Cdelta and calcium-dependent protein kinase C gamma. FEBS Lett 1997; 400: 226-32.
33. Sakurai Y, Onishi Y, Tanimoto Y, Kizaki H. Novel Protein Kinase Cδ Isoform Insensitive to Caspase-3. Biol Pharm Bull 2001; 24: 973-7.
34. Ueyama T, Ren Y, Ohmori S, Sakai K, Tamaki N, Saito N. cDNA Cloning of an Alternative Splicing Variant of Protein Kinase Cδ (PKCδIII), a New Truncated Form of PKC, in Rats. Biochem Biophys Res Commun 2000; 269: 557-563.
35. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ. Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem 1999; 274: 34758-64.
36. Takahashi M, Mukai H, Oishi K, Isagawa T, Ono Y. Association of immature hypophosphorylated protein kinase Cepsilon with an anchoring protein CG-NAP. J Biol Chem 2000; 275: 34592-6.
37. Nanahoshi M, Nishizuka T, Tsujishita Y, Hara K, Inui S, Sakaguchi N, et al. Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. Biochem Biophys Res Commun 1998; 251: 520-6.
38. England K, Watson J, Beale G, Warner M, Cross J, Rumsby M. Signalling pathways regulating the dephosphorylation of Ser729 in the hydrophobic domain of protein kinase Cepsilon upon cell passage. J Biol Chem 2001; 10437-42.
39. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998; 281: 2042-5.
40. Stempka L, Schnolzer M, Rincke G, Marks F, Gschwendt M. In ASBMB Symposium on Protein Kinase C and Cellular Function, Oct. 9-12, 1998, Abstract 33.
41. Stempka L, Schnolzer M, Radke S, Rincke G, Marks F, Gschwendt M. Requirements of protein kinase cdelta for catalytic function. Role of glutamic acid 500 and autophosphorylation on serine 643. J Biol Chem 1999: 274: 8886-92.
42. Stempka L, Girod A, Muller HJ, Rincke G, Marks F, Gschwendt M, et al. Phosphorylation of protein kinase Cdelta (PKCdelta) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form. J Biol Chem 1997; 272: 6805-11.
43. Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 2000; 484: 217-23.
44. Li W, Zhang J, Bottaro DP, Pierce JH. Identification of serine 643 of protein kinase C-delta as an important autophosphorylation site for its enzymatic activity. J Biol Chem 1997; 272: 24550-5.
45. Kumar V, Pandey P, Sabatini D, Kumar M, Majumder PK, Bharti A, et al. Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation. EMBO J 2000; 19: 1087-97.
46. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ. Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem 1999; 274: 34758-64.
47. Kronfeld I, Kazimirsky G, Lorenzo PS, Garfield SH, Blumberg PM, Brodie C. Phosphorylation of protein kinase Cdelta on distinct tyrosine residues regulates specific cellular functions. J Biol Chem 2000; 275: 35491-8.
48. Li W, Jiang YX, Zhang J, Soon L, Flechner L, Kapoor V, et al. Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol Cell Biol 1998; 18: 5888-98.
49. Denning MF, Dlugosz AA, Threadgill DW, Magnuson T, Yuspa SH. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem 1996; 271: 5325-31.
50. Haleem-Smith H, Chang EY, Szallasi Z, Blumberg PM, Rivera J. Tyrosine phosphorylation of protein kinase C-delta in response to the activation of the high-affinity receptor for immunoglobulin E modifies its substrate recognition. Proc Natl Acad Sci USA 1995; 92: 9112-6.
51. Li W, Mischak H, Yu JC, Wang LM, Mushinski JF, Heidaran MA, et al. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J Biol Chem 1994; 269: 2349-52.
52. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, et al. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 1997; 94: 11233-7.
53. Soltoff SP, Toker A. Carbachol, substance P, and phorbol ester promote the tyrosine phosphorylation of protein kinase C delta in salivary gland epithelial cells. J Biol Chem 1995; 270: 13490-5.
54. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem (Tokyo) 2002; 132: 831-9
55. Gschwendt M. Protein kinase C delta. Eur J Biochem 1999; 259: 555-64.
56. Gschwendt M, Kielbassa K, Kittstein W, Marks F. Tyrosine phosphorylation and stimulation of protein kinase C delta from porcine spleen by src in vitro. Dependence on the activated state of protein kinase C delta. FEBS Lett 1994; 347: 85-9.
57. Shanmugam M, Krett NL, Peters CA, Maizels ET, Murad FM, Kawakatsu H, et al. Association of PKC delta and active Src in PMA-treated MCF-7 human breast cancer cells. Oncogene 1998; 16: 1649-54.
58. Zang Q, Lu Z, Curto M, Barile N, Shalloway D, Foster DA. Association between v-Src and protein kinase C delta in v-Src-transformed fibroblasts. J Biol Chem 1997; 272: 13275-80.
59. Song JS, Swann PG, Szallasi Z, Blank U, Blumberg PM, Rivera J. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta. Oncogene 1998; 16: 3357-68.
60. Sun X, Wu F, Datta R, Kharbanda S, Kufe D. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 2000; 275: 7470-3.
61. Yuan ZM, Utsugisawa T, Ishiko T, Nakada S, Huang Y, Kharbanda S, et al. Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 1998; 16: 1643-8.
62. Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y. et al. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 2001; 98: 6587-92.
63. Wrenn RW. Carbachol stimulates TYR phosphorylation and association of PKCdelta and PYK2 in pancreas. Biochem Biophys Res Commun 2001; 282: 882-6.
64. Deszo EL, Brake DK, Cengel KA, Kelley KW, Freund GG. CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta. J Biol Chem 2001; 276: 10212-7.
65. Denning MF, Dlugosz AA, Howett MK, Yuspa SH. Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta. J Biol Chem 1993; 268: 26079-81.
66. Edmondson RD, Vondriska TM, Biederman KJ, Zhang J, Jones RC, Zheng Y, et al. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics 2002; 1: 421-33.
67. Wu D, Foreman TL, Gregory CW, McJilton MA, Wescott GG, Ford OH, et al. Protein kinase C epsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res 2002; 62: 2423-9;
68. Wu D, Terrian DM. Regulation of caveolin-1 expression and secretion by a protein kinase Cepsilon signaling pathway in human prostate cancer cells. J Biol Chem 2002; 277: 40449-55.
69. McJilton MA, Van Sikes C, Wescott GG, Wu D, Foreman TL, Gregory CW, et al. Protein kinase C epsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 2003; 22: 7958-68.
70. Wu D, Thakore CU, Wescott GG, McCubrey JA, Terrian DM. Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells. Oncogene 2004; 23: 8659-72.
71. 2+ channels. Nat Neurosci 2003; 6: 468-75.
72. Kuroda S, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, Mizuno K, et al. Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem 1996; 271: 31029-32.
73. Varley CL, Brown BL, Groome N, Dobson PRM. Interleukin 1β-induced expression of Protein kinase C (PKC) δ AND ε IN NIH 3T3 cells. Cytokine 1997; 8: 466-70.
74. Novotny-Diermayr V, Zhang T, Gu L, Cao X. Protein Kinase Cδ Associates with the Interleukin-6 Receptor Subunit Glycoprotein (gp) 130 via Stat3 and Enhances Stat3-gp130 Interaction. J Biol Chem 2002; 277: 49134-42.
75. Jain N, Zhang T, Kee WH, Li W, Cao X. Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner. J Biol Chem 1999; 274: 24392-400.
76. Thabard W, Collette M, Bataille R, Amiot M. Protein kinase Cδ and η isoenzymes control the shedding of the interleukin 6 receptor α in myeloma cells. Biochem J 2001; 358: 193-200.
77. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, et al. Protein Kinase C-δ (PKC-δ) Is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002; 277: 14408-16.
78. Rosenzweig T, Aga-Mizrachi S, Bak A, Sampson SR. Src tyrosine kinase regulates insulin-induced activation of protein kinase C (PKC)δ in skeletal muscle. Cell Signal 2004; 16: 1299-1308.
79. Shanmugam M, Krett NL, Maizels ET, Cutler RE, Peters CA, Smith LM, et al. Regulation of protein kinase Cδ by estrogen in the MCF-7 human breast cancer cell line. Mol Cell Endocrinol 1999; 148: 109-18.
80. Kima, IS, Ryangb YS, Kima YS, Janga SW, Sunga HJ, Leec YH, et al. Leukotactin-1-induced ERK activation is mediated via Gi/Go protein/PLC/ PKCδ/Ras cascades in HOS cells. Life Sci 2003; 73: 447-59.
81. Nishikawa K, Toker A, Johannes FJ, Songyang Z, Cantley LC. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 1997; 272: 952-60.
82. Kielbassa K, Muller HJ, Meyer HE, Marks F, Gschwendt M. Protein kinase C delta-specific phosphorylation of the elongation factor eEFalpha and an eEF-1 alpha peptide at threonine 431. J Biol Chem 1995: 270: 6156-62.
83. Schullery DS, Ostrowski J, Denisenko ON, Stempka L, Shnyreva M, Suzuki H, et al. Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein. J Biol Chem 1999; 274: 15101-9.
84. Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, Yuan ZM, et al. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 1998; 18: 6719-28.
85. Cross T, Griffiths G, Deacon E, Sallis R, Gough M, Watters D, et al. PKC-delta is an apoptotic lamin kinase. Oncogene 2000; 19: 2331-7.
86. Liu J, Chen J, Dai Q, Lee RM. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res 2003; 63: 1153-6.
87. Ren J, Datta R, Shioya H, Li Y, Oki E, Biedermann V, et al. p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 2002; 277: 33758-65.
88. Reich NC, Pfeffer LM. Evidence for involvement of protein kinase C in the cellular response to interferon alpha. Proc Natl Acad Sci USA 1990; 87: 8761-5.
89. Alvaro V, Prevostel C, Joubert D, Slosberg E, Weinstein BI. Ectopic expression of a mutant form of PKCε originally found in human tumors: aberrant subcellular translocation and effects on growth control. Oncogene 1997; 14: 677-85.
90. Knauf JA, Elisei R, Mochly-Rosen D, Liron T, Chen XN, Gonsky JR, et al. Involvement of protein kinase Cε (PKCε) in thyroid cell death. A truncated chimeric PKCε cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. J Biol Chem 1999; 274: 23414-25.
91. Knauf JA, Ward LS, Nikiforov YE, Nikiforova M, Puxeddu E, Medvedovic M, et al. Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon. J Clin Endocrinol Metab 2002; 87: 2150-59.
92. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Murphy JP, Kirschmeier P, et al. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 1988; 52: 343-54.
93. Borner C, Guadagno SN, Hsieh LL, Hsiao WL, Weinstein IB. Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon. Cell Growth Differ 1990; 1: 653-60.
94. Borner C, Filipuzzi I, Weinstein IB, Imber R. Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblasts. Nature 1991; 353: 78-80.
95. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, et al. Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993; 268: 6090-6.
96. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993; 8: 2095-2104.
97. Han EK, Cacace AM, Sgambato A, Weinstein IB. Altered expression of cyclins and c-fos in R6 cells that overproduced PKCε. Carcinogenesis 1995; 16: 2423-8.
98. Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, Weinstein IB. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 1996; 13: 2517-26.
99. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997; 17: 732-41.
100. Ueffing M, Lovric J, Philipp A, Mischak H, Kolch W. Protein kinase C-ε associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity. Oncogene 1997; 15: 2921-7.
101. Perletti GP, Folini M, Lin HC, Mischak H, Piccinini F, Tashjian AH Jr. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogene 1996; 12: 847-54.
102. Perletti GP, Concari P, Brusaferri S, Marras E, Piccinini F, Tashjian AH Jr. Protein kinase Cε is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway. Oncogene 1998; 16: 3345-8.
103. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003; 278: 13061-8.
104. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003; 426: 574-9.
105. Sharif TR, Sharif M. Overexpression of protein kinase C-ε in astroglial brain tumor derived cell lines and primary tumor samples. Int J Oncology 1999; 15: 237-43.
106. Sharif TR, Sasakawa N, Sharif M. Regulated expression of a dominant negative protein kinase C epsilon mutant inhibits the proliferation of U-373MG human astrocytoma cells. Int J Mol Med 2001; 7: 373-80.
107. Song MS, Park YK, Lee J-H, Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-ε/ERK/AP-1 signaling cascade. Cancer Res 2001; 61: 8322-30.
108. Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM, Mufson RA. Overexpression of protein kinase C isoform ε but not δ in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood 1998; 91: 823-9.
109. Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM, Mufson RA. Overexpression of protein kinase C isoform ε but not δ in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood 1998; 91: 823-9.
110. Suzuki A, Goto Y, Iguchi T. Progression of PDMT is accompanied by lack of Fas intense expression and Bcl-2 and PKC-epsilon. Carcinogenesis 1997; 18: 883-7.
111. Gillespie S, Zhang XD, Hersey P. Variable expression of protein kinase Cε in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis. Mol Cancer Ther 2005; 4: 668-76.
112. Reddig PJ, Dreckschmidt NE, Zou J, Bourguignon SE, Oberley TD, Verma AK. Transgenic mice overexpressing protein kinase Cε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res 2000; 60: 595-602.
113. Jansen AP, Verwiebe EG, Dreckschmimdt NE, Wheeler DL, Oberley TD, Verma AK. Protein kinase C-ε transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res 2001; 61: 808-12.
114. Jansen AP, Dreckschmimdt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer 2001; 93: 635-43.
115. Wheeler DL, Martin KE, Ness KJ, Li Y, Dreckschmidt NE, Wartman M, et al. Protein kinase Cε is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res 2004; 64: 7756-65.
116. Wheeler DL, Li Y, Verma AK. Protein kinase C epsilon signal ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through induction of specific cytokines in a paracrine mechanism. Photochem Photobiol 2005; 81: 9-18.
117. Craven PA, DeRubertis FR. Alterations in protein kinase C in 1,2-dimethylhydrazine induced colonic carcinogenesis. Cancer Res 1992; 52: 2216-2221.
118. Kopp R, Noelke B, Sauter G, Schildberg FW, Paumgartner G, Pfeiffer A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 1991; 51: 205-210.
119. Levy MF, Pocsidio J, Guillem JG, Forde K, LoGerfo P, Weinstein IB. Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors. Dis Colon Rectum 1993; 36: 913-921.
120. McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci 1994; 39: 458-463.
121. Craven PA, DeRubertis FR. Loss of protein kinase C delta isozyme immunoreactivity in human adenocarcinomas. Dig Dis Sci 1994; 39: 481-9.
122. Li W, Jiang YX, Zhang J, Soon L, Flechner L, Kapoor V, et al. Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol Cell Biol 1998; 18: 5888-98.
123. Kin Y, Shibuya M, Maru Y. Inhibition of protein kinase C delta has negative effect on anchorage-independent growth of BCR-ABL-transformed Rat1 cells. Leuk Res 2001; 25: 821-5.
124. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993; 268: 6090-6.
125. Lu Z, Hornia A, Jiang YW, Zang Q, Ohno S, Foster DA. Tumor promotion by depleting cells of protein kinase C delta. Mol Cell Biol 1997; 17: 3418-28.
126. Hornia A, Lu Z, Sukezane T, Zhong M, Joseph T, Frankel P, et al. Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Mol Cell Biol 1999; 19: 7672-80.
127. Perletti GP, Marras E, Concari P, Piccinini F, Tashjian AH Jr. PKCdelta acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene 1999; 18: 1251-6.
128. Cerda SR, Bissonnette M, Scaglione-Sewell B, Lyons MR, Khare S, Mustafi R, et al. PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 2001; 120: 1700-12.
129. La Porta CA, Comolli R. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis. Carcinogenesis 1995 16: 1233-8.
130. Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer 2001; 93: 635-43.
131. Braun MU, Mochly-Rosen D. Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J Mol Cell Cardiol 2003; 35: 895-903.
132. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, et al. Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem 2003; 278: 32544-51.
133. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA 1992; 890: 10159-63.
134. Griffiths G, Garrone B, Deacon E, Owen P, Pongracz J, Mead G, et al. The polyether bistratene A activates protein kinase C-delta and induces growth arrest in HL60 cells. Biochem Biophys Res Commun 1996; 222: 802-8.
135. Kitamura K, Mizuno K, Etoh A, Akita Y, Miyamoto A, Nakayama K, et al. The second phase activation of protein kinase C delta at late G1 is required for DNA synthesis in serum-induced cell cycle progression. Genes Cells. 2003; 8: 311-24.
136. Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res 2004; 299: 159-70.
137. Stetak A, Lankenau A, Vantus T, Csermely P, Ullrich A, Keri G. The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src. Biochem Biophys Res Commun 2001; 285: 483-8.
138. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S, et al. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 1997; 272: 13816-22.
139. Harrington EO, Loffler J, Nelson PR, Kent KC, Simons M, Ware JA. Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem 1997; 272: 7390-7.
140. Ashton AW, Watanabe G, Albanese C, Harrington EO, Ware JA, Pestell RG. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). J Biol Chem 1999; 274: 20805-11.
141. Page K, Li J, Corbit KC, Rumilla KM, Soh JW, Weinstein IB, et al. Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. Am J Respir Cell Mol Biol 2002; 27: 204-13.
142. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q. et al. Identification of BTG2. an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996; 14: 482-6.
143. Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G, et al. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 2000; 20: 1797-815.
144. Ohba M, Ishino K, Kashiwagi M, Kawabe S, Chida K, Huh NH, et al. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. Mol Cell Biol 1998; 18: 5199-207.
145. Efimova T, Deucher A, Kuroki T, Ohba M, Eckert RL. Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/ enhancer-binding protein alpha. J Biol Chem. 2002; 277: 31753-60.
146. Joseloff E, Cataisson C, Aamodt H, Ocheni H, Blumberg P, Kraker AJ, et al. Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J Biol Chem 2002; 277: 12318-23.
147. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. J Biol Chem 1993; 268: 20110-5.
148. Wang QJ, Acs P, Goodnight J, Blumberg PM, Mischak H, Mushinski JF. The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and -epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation. Oncogene 1998; 16: 53-60.
149. O'Driscoll KR, Teng KK, Fabbro D, Greene LA, Weinstein IB. Selective translocation of protein kinase C-delta in PC12 cells during nerve growth factor-induced neuritogenesis. Mol Biol Cell 1995; 6: 449-58.
150. Rosdahl JA, Mourton TL, Brady-Kalnay SM. Protein kinase C delta (PKCdelta) is required for protein tyrosine phosphatase mu (PTPmu)-dependent neurite outgrowth. Mol Cell Neurosci 2002; 19: 292-306.
151. Perletti G, Marras E, Dondi D, Osti D, Congiu T, Ferrarese R, et al. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells. Int J Cancer 2005; 113: 42-53.
152. Perletti G, Marras E, Osti D, Felici L, Zaro S, de Eguileor M. PKCdelta requires p53 for suppression of the transformed phenotype in human colon cancer cells. J Cell Mol Med 2004; 8: 563-9.
153. Gutcher I, Webb PR, Anderson NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 2003; 60: 1061-70.
154. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 2003 8: 19-27.
155. Basu A. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 2003; 7: 341-50.
156. Reyland ME, Anderson SM, Matassa AA, Barzen KA, Quissell DO. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem 1999; 274: 19115-23.
157. Blass M, Kronfeld I, Kazimirsky G, Blumberg PM, Brodie C. Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 2002; 22: 182-95.
158. Konishi H, Matsuzaki H, Takaishi H, Yamamoto T, Fukunaga M, Ono Y, et al. Opposing effects of protein kinase C delta and protein kinase B alpha on H(2)O(2)-induced apoptosis in CHO cells. Biochem Biophys Res Commun 1999; 264: 840-6.
159. Zrachia A, Dobroslav M, Blass M, Kazimirsky G, Kronfeld I, Blumberg PM, et al. Infection of glioma cells with Sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C delta. Implications for Sindbis virus-induced apoptosis. J Biol Chem 2002; 277: 23693-701.
160. Shizukuda Y, Reyland ME, Buttrick PM. Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol 2002; 282: H1625-34.
161. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, et al. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem 2000; 275: 7574-82.
162. Fukunaga M, Oka M, Ichihashi M, Yamamoto T, Matsuzaki H, Kikkawa U. UV-induced tyrosine phosphorylation of PKC delta and promotion of apoptosis in the HaCaT cell line. Biochem Biophys Res Commun 2001; 289: 573-9.
163. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 2002; 22: 1738-51.
164. Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, et al. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 1999; 29: 2603-12.
165. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 1995; 14: 6148-56.
166. Yuan ZM, Utsugisawa T, Ishiko T, Nakada S, Huang Y, Kharbanda S, et al. Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 1998; 16: 1643-8.
167. Lee YJ, Soh JW, Dean NM, Cho CK, Kim TH, Lee SJ, et al. Protein kinase Cdelta overexpression enhances radiation sensitivity via extracellular regulated protein kinase 1/2 activation, abolishing the radiation-induced G(2)-M arrest. Cell Growth Differ 2002; 13: 237-46.
168. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, et al. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996; 184: 2399-404.
169. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 1995; 14: 6148-56.
170. Goerke A, Sakai N, Gutjahr E, Schlapkohl WA, Mushinski JF, Haller H, et al. Induction of apoptosis by protein kinase C delta is independent of its kinase activity. J Biol Chem 2002; 277: 32054-62.
171. Basu A, Akkaraju GR. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 1999; 38: 4245-51.
172. Reyland ME, Anderson SM, Matassa AA, Barzen KA, Quissell DO. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem 1999; 274: 19115-23.
173. Leverrier S, Vallentin A, Joubert D. Positive feedback of protein kinase C proteolytic activation during apoptosis. Biochem J 2002; 368(Pt 3): 905-13.
174. Zhang XM, Chen J, Xia YG, Xu Q. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alpha and translocating PKC-delta. Cancer Chemother Pharmacol 2005; 55: 251-62.
175. Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, et al. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 1999; 29: 2603-12.
176. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH. Premature p34cdc2 activation required for apoptosis. Science 1994; 263: 1143-5.
177. Eitel K, Staiger H, Rieger J, Mischak H, Brandhorst H, Brendel MD, et al. Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 2003; 52: 991-7.
178. Majumder PK, Pandey P, Sun X, Cheng K, Datta R, Saxena S, et al. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 2000; 275: 21793-6.
179. Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, et al. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 2001; 12: 465-70.
180. Liu J, Chen J, Dai Q, Lee RM. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res 2003; 63: 1153-6.
181. Disatnik M-H, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res 1997; 210: 287-97.
182. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 1994; 74: 299-309.
183. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinae C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 1999; 31: 1937-48.
184. Gray MO, Karliner JS, Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997; 272: 30945-51.
185. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, et al. Opposing cardioprotective actions and parallel hypertrophy effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 2001; 98: 11114-9.
186. Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 2001; 88: 59-62.
187. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, Marber MS. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 2002; 55: 672-80.
188. Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, et al. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res 2005; 96: 748-55.
189. Vondriska TM, Zhang J, Song C, Tang XL, Cao X, Baines CP, et al. Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ Res 2001; 88: 1306-13.
190. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, et al. Formation of protein kinase C (epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 2002; 109: 499-507.
191. Besana A, Barbuti A, Tateyama MA, Symes AJ, Robinson RB, Feinmark SJ. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. J Biol Chem 2004; 279: 33154-60.
192. Uecker M, Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M. Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. Anesthesiology 2003; 99: 138-47.
193. Fryer RM, Wang Y, Hsu AK, Gross GJ. Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 2001; 280: H1346-53.
194. Kudo M, Wang Y, Xu M, Ayub A, Ashraf M. Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am J Physiol Heart Circ Physiol 2002; 283: H296-301.
195. Zhao TC, Kukreja RC. Protein kinase C-delta mediates adenosine A3 receptor-induced delayed cardioprotection in mouse. Am J Physiol Heart Circ Physiol 2003; 285: H434-41.
196. Wang Y, Hirai K, Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res 1999; 85: 731-41.
197. Neckar J, Markova I, Novak F, Novakova O, Szarszoi O, Ost'adal B, et al. Increased expression and altered subcellular distribution of PKC-delta in chronically hypoxic rat myocardium: involvement in cardioprotection. Am J Physiol Heart Circ Physiol 2005; 288: H1566-72.
198. Fryer RM, Hsu AK, Wang Y, Henry M, Eells J, Gross GJ. PKC-delta inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats. Basic Res Cardiol 2002; 97: 47-54.
199. Mayr M, Metzler B, Chung YL, McGregor E, Mayr U, Troy H, et al. Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol 2004; 287: H946-56.
200. Mayr M, Chung YL, Mayr U, McGregor E, Troy H, Baier G, et al. Loss of PKC-delta alters cardiac metabolism. Am J Physiol Heart Circ Physiol 2004; 287: H937-45.
201. Larsen EC, DiGennaro JA, Saito N, Mehta S, Loegering DJ, Mazurkiewicz JE, et al. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol 2000; 165: 2809-17.
202. Diaz-Guerra MJ, Bodelon OG, Velasco M, Whelan R, Parker PJ, Bosca L. Up-regulation of protein kinase C-ε promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J Biol Chem 1996; 271: 32028-33.
203. Castrillo A, Pennington DJ, Otto F, Parker PJ, Owen MJ, Bosca L. Protein kinase Cε is required for macrophage activation and defense against bacteria. J Exp Med 2001; 194: 1231-42.
204. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002; 416: 865-9.
205. Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 2002; 416: 860-5.
206. Hanauske AR, Sundell K, Lahn M. The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen. Curr Pharm Des 2004; 10(16): 1923-36.
207. Hool LC. Protein kinase C isozyme selective peptides--a current view of what they tell us about location and function of isozymes in the heart. Curr Pharm Des 2005; 11(4): 549-59.
208. Irie K, Nakagawa Y, Ohigashi H. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes. Curr Pharm Des 2004; 10(12): 1371-85.